ESCROW AGREEMENT (PUBLIC OFFERING)Escrow Agreement • June 20th, 2018 • Provention Bio, Inc. • Pharmaceutical preparations • New York
THIS AGREEMENT (this “Agreement”) is made this June __, 2018 by and among Provention Bio, Inc. (the “Issuer”) and the Underwriter whose name and address appears on the Information Sheet (as defined herein) attached to this Agreement and Continental Stock Transfer & Trust Company, 1 State Street, 30th Floor, New York, New York 10004 (the “Escrow Agent”).
ASSET PURCHASE AGREEMENTPatent Assignment Agreement • June 20th, 2018 • Provention Bio, Inc. • Pharmaceutical preparations • Delaware
This Asset Purchase Agreement (this “Agreement”) is made and entered into as of the 7th day of May 2018 (the “Closing Date”), by and between
LICENSE AGREEMENT BY AND BETWEEN MACROGENICS, INC. AND PROVENTION BIO, INC. LIST OF EXHIBITSLicense Agreement • June 20th, 2018 • Provention Bio, Inc. • Pharmaceutical preparations • Delaware
This LICENSE AGREEMENT (this “Agreement”) is entered into as of May 7, 2018 (the “Effective Date”), by and between PROVENTION BIO, INC., a Delaware corporation, having its principal place of business at 110 Old Driftway Lane, Lebanon, NJ 08833 (“Provention”) and MACROGENICS, INC., a Delaware corporation having its principal place of business at 9704 Medical Center Drive, Rockville, MD 20850 (hereinafter “MacroGenics”). Provention and MacroGenics are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
